Covid Update #11: Back to school, flu shots and Saturdays! A message from Dr. Lieberman and Dr. Parekh Food allergies, asthma and back to school: Please ensure all anaphylaxis emergency care plans (ECP) and epinephrine prescriptions are up to date. If your child has asthma, be sure to check the status of…
Category: anaphylaxis
Covid-19 Update #7
Covid-19, Update #7: A message from Dr. Lieberman and Dr. Parekh: Friends, We would like to share the following reminder from Austin Public Health. It contains valuable information regarding emergency treatment during this special time. As always, we stress the best way to prevent an asthma emergency is to remain on your daily asthma medications…
Palforzia FDA approved
On Friday, the FDA approved Palforzia, the first drug to treat peanut allergy. Although approved, it is not yet available. We plan to begin using Palforzia as soon as it becomes widely available. If you or your child has peanut allergy, please call us to schedule an evaluation and determine eligibility
Dr. L food allergy Q&A
In this month’s issue of Texas Medicine, Dr. Lieberman had an insightful Q&A that reflects his deep knowledge about the food allergy epidemic. You can read it here. Some highlights include: 8% of kids have a food allergy. This rise in food allergies caught everyone (e.g. schools, restaurants, airlines) unprepared. Texas has passed legislation to…
Allergy Bills that passed in 2019
The 2019 Texas Legislative Session, the 86th one, has finished. Below is a quick summary of the bills the State Allergy, Asthma & Immunology Society supported. As in years past, Dr. Parekh and Dr. Lieberman attended First Tuesdays at the Capitol to advocate for these bills with our state legislators! HB4260 relating to the possession…
It's Food Allergy Awareness Week!
This is the 21st Food Allergy Awareness Week and this year Gov. Abbot has also recognized it in the state of Texas! From FARE’s website: “more than 32 million Americans are managing food allergy. Through increased awareness, we can promote respect, safety and inclusion and ensure that communities have the tools they need to spread…
Oral Immunotherapy (OIT) Update
We began our oral immunotherapy program almost two years ago and are pleased to report 34 patients have been enrolled. We now offer OIT for 4 foods: peanut, milk, egg and cashew/pistachio. Of the 34, 32 are for peanut OIT and one each for milk and egg. 23 have completed and are now consuming a…
new peanut allergy treatment study
There is been a lot of press recently about a new FDA approved treatment for peanut allergy. As food allergy specialists, we are certainly excited about additional treatment options for patients. For years avoidance was the mainstay of care and accidental exposure to trace amounts of peanut could be dangerous for the sensitive patient. This…
OIT Update
What a big day! Anna ate her first peanut yesterday after 3 months of therapy. Way to go Anna! Here is our latest OIT progress report: We enrolled our first peanut OIT patient in June of 2017. We have now enrolled a total of 21 patients including 2 new starts last week with another new…
Update on EpiPen Shortage
The FDA has extended the expiration date on certain lots of EpiPens in response to the current shortage. The indicated lots have been deemed safe for an additional four months, according to the FDA, who reviewed data provided by Mylan prior to their decision. They hope this will help to mitigate the shortage during back-to-school…